← Back to patent-cliff list
沙格列汀水合物
Tier C — Watch / tradeSaxagliptin Hydrate
百时美施贵宝
Originator
2009
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：DPP4
Brand：Onglyza、安立泽
Indications (approved)：二型糖尿病
Regional status
US
撤市
EU
批准上市
2009-09-30
China
批准上市
2011-05-05
Japan
批准上市
2013-03-25
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Saxagliptin Hydrate?
Approved indications include: 二型糖尿病.
When does the Saxagliptin Hydrate patent expire?
No public expiry year is available for Saxagliptin Hydrate yet; this page updates once verified.
How do I get a quote for Saxagliptin Hydrate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25